Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms

Acta Haematologica

Volumn 129, Issue 3, 2013, Pages 187-196

  Hauck, Gesa ^a   Jonigk, Danny ^a   Kreipe, Hans ^a   Hussein, Kais ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Concurrent neoplasms; Haematopathology; Lymphoma; Myeloproliferative neoplasm; Plasmacytoma

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; B CELL LYMPHOMA; BONE MARROW CELL; CANCER STEM CELL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; NONHODGKIN LYMPHOMA; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PLASMACYTOID DENDRITIC CELL; PLASMACYTOMA; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; T CELL LYMPHOMA; AMINO ACID SUBSTITUTION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; METABOLISM; MISSENSE MUTATION; PATHOLOGY; RETROSPECTIVE STUDY; SECOND CANCER; B CELL LEUKEMIA; BONE MARROW TUMOR; CHROMOSOME ABERRATION; GENE MUTATION; LYMPHATIC SYSTEM TUMOR; WALDENSTROEM MACROGLOBULINEMIA;

JAK2 PROTEIN, HUMAN; JANUS KINASE 2; STEM CELL FACTOR RECEPTOR; STEM CELL FACTOR;

AMINO ACID SUBSTITUTION; FEMALE; HUMANS; JANUS KINASE 2; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MUTATION, MISSENSE; NEOPLASMS, SECOND PRIMARY; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES;

MLCS; MLOWN;

EID: 84871209259     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000342484     Document Type: Article

References (103)

1. Royle JA, Baade PD, Joske D, Girschik J, Fritschi L: Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer 2011; 105: 1076-1081
2. Bhatia R, Deeg HJ: Treatment-related myelodysplastic syndrome: molecular characteristics and therapy. Curr Opin Hematol 2011; 18: 77-82
3. George TI, Horny HP: Systemic mastocytosis. Hematol Oncol Clin North Am 2011; 25: 1067-1083, vii
4. Sotlar K, Colak S, Bache A, Berezowska S, Krokowski M, Bültmann B, Valent P, Horny HP: Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). J Pathol 2010; 220: 586-595
5. Bocchia M, Vannucchi AM, Gozzetti A, Guglielmelli P, Poli G, Crupi R, Defina M, Bosi A, Lauria F: Insights into JAK2-V617F mutation in CML. Lancet Oncol 2007; 8: 864- 866 (Pubitemid 47488062)
6. Hussein K, Bock O, Theophile K, Seegers A, Arps H, Basten O, Grips KH, Franz-Werner J, Büsche G, Kreipe H: Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation. Leukemia 2008; 22: 1059-1062 (Pubitemid 351689890)
7. Hussein K, Horny HP, Büsche G, Görner M, Göhring G, Kreipe H, Bock O: Systemic mastocytosis (SM) with associated BCR-ABLpositive myelogenous leukaemia (SMAHNMD): evidence that mast cells do not belong to the leukaemic clone. Leukemia 2011; 25: 1050-1053
8. Oka K, Nagayama R, Yonekawa N, Nihei T, Sando N, Yatabe Y, Mori N: Concurrent gastric MALT and Hodgkin lymphoma: a case report. Int J Surg Pathol 2012; 20: 201-204
9. Camós M, Cervantes F, Montoto S, Hernández- Boluda JC, Villamor N, Montserrat E: Acute lymphoid leukemia following polycythemia vera. Leuk Lymphoma 1999; 32: 395- 398 (Pubitemid 29087825)
10. Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES: Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol 2011; 24: 1421-1432
11. Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Foà R: The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience. Am J Hematol 2011; 86: 1007-1012
12. Florensa L, Vallespí T, Woessner S, Domingo A, Crespo N, Rozman M, Aguilar JL, Irriguible D, Zarco A, Millá F, Feliu E: Incidence and characteristics of lymphoid malignancies in untreated myelodysplastic syndromes. Leuk Lymphoma 1996; 23: 609-612 (Pubitemid 27029673)
13. Hussein K, Brakensiek K, Ballmaier M, Bormann M, Göhring G, Buhr T, Bock O, Kreipe H: B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol 2006; 77: 539-541 (Pubitemid 44690804)
14. Kremer M, Horn T, Koch I, Dechow T, Gattenloehner S, Pfeiffer W, Quintanilla-Martínez L, Fend F: Quantitation of the JAK2V617F mutation in microdissected bone marrow trephines: equal mutational load in myeloid lineages and rare involvement of lymphoid cells. Am J Surg Pathol 2008; 32: 928-935
15. Kodali S, Chen C, Rathnasabapathy C, Wang JC: JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN). Leuk Res 2009; 33:e236-e239
16. Musolino C, Allegra A, Penna G, Centorrino R, Cuzzola M, D'Angelo A, Iacopino P, Alonci A: Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders. Acta Haematol 2009; 122: 46-49
17. Abeliovich D, Yehuda O, Ben-Neriah S, Matzner Y: Therapy-related myelodysplastic syndrome. Two cytogenetically unrelated abnormal clones in a patient with multiple myeloma. Cancer Genet Cytogenet 1993; 70: 117-119 (Pubitemid 23355346)
18. Acar H, Ecirli S, Gündoǧan F, Bulay O, Acar A: Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis. Cancer Genet Cytogenet 1999; 108: 171-174 (Pubitemid 29021965)
19. Arlen PM, Goldkland GA: Multiple myeloma after treatment of essential thrombocythemia. South Med J 1995; 88: 79-81
20. Aviv H, Tang D, Das K, Harrison JS, Hameed M, Varma M: Simultaneous appearance of trisomy 8 and trisomy 12 in different cell populations in a patient with untreated Bcell chronic lymphocytic leukemia and myelodysplasia. Leuk Lymphoma 2004; 45: 1279-1283 (Pubitemid 38584914)
21. Au WY, Ma SK, Wan TS, Wang EP, Lau TC, Kwong YL: Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy. Leuk Lymphoma 2003; 44: 535- 538 (Pubitemid 36113902)
22. Botelho de Sousa A, Gouveia J: Coexistent chronic lymphocytic leukemia and polycythemia vera requiring no treatment. Med Oncol Tumor Pharmacother 1989; 6: 239- 240 (Pubitemid 19257287)
23. Bosch F, Cervantes F, Lopez-Guillermo A, Carreras E, Montserrat E, Rozman C: Polycythaemia vera following non-Hodgkin's lymphoma. Leuk Lymphoma 1992; 8: 501- 502 (Pubitemid 23132544)
24. Breccia M, Petti MC, D'Elia GM, D'Andrea M, Carmosino I, Alimena G: Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen. Eur J Haematol 2002; 68: 1-3 (Pubitemid 34407536)
25. Callea V, Brugiatelli M, Stelitano C, Gentile M, Nobile F, Morabito F: Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy. Leuk Lymphoma 2006; 47: 2314-2320 (Pubitemid 44773213)
26. Carulli G, Marini A, Baicchi U, Simi P, Papineschi F, Ambrogi F: Chronic lymphocytic leukemia (B-cell) in the course of polycythemia vera. Description of a case with an unusual chromosomic anomaly. Tumori 1987; 73: 639-643 (Pubitemid 18039127)
27. Cobo F, Cervantes F, Martinez C, Salgado C, Blade J, Montserrat E, Rozman C: Multiple myeloma following essential thrombocythemia. Leuk Lymphoma 1995; 20: 177-179 (Pubitemid 26007449)
28. Cottrill C, Geller A, diSpaltro FX, Weissglass B, Klainer AS, Bisaccia E: Control of polycythaemia vera with photochemotherapy in a patient with cutaneous T-cell lymphoma. Br J Haematol 1994; 86: 225-226 (Pubitemid 24194415)
29. Economopoulos T, Pappa V, Panani A, Stathakis N, Dervenoulas J, Papageorgiou E, Asprou N, Raptis S: Myelopathies during the course of multiple myeloma. Haematologica 1991; 76: 289-292
30. Fink L, Bauer F, Perry JJ: Coincidental polycythemia vera and multiple myeloma: case report and review. Am J Hematol 1993; 44: 196-200 (Pubitemid 23295703)
31. Fukuda N, Shinohara K, Ota I, Muraki K, Shimohakamada Y: Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma. Int J Hematol 2002; 75: 67-71 (Pubitemid 43014041)
32. Gabrail NY, Martin TW: Coexistence of essential thrombocythemia and chronic lymphocytic leukemia. Acta Haematol 1991; 85: 31-33
33. Govindarajan R, Jagannath S, Flick JT, Vesole DH, Sawyer J, Barlogie B, Tricot G: Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma. Br J Haematol 1996; 95: 349-353 (Pubitemid 26360224)
34. Harrison P, Neilson JR, Lumley MA, Milligan DW: Development of polycythaemia rubra vera following treatment for centroblastic lymphoma. Acta Haematol 1996; 96: 113- 114 (Pubitemid 26245670)
35. Hauswirth AW, Födinger M, Fritz M, Müllauer L, Simonitsch-Klupp I, Streubel B, Chott A, Sperr WR, Jäger U, Valent P: Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease. Hum Pathol 2008; 39: 917-924
36. Horny HP, Sotlar K, Stellmacher F, Valent P, Grabbe J: An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). J Clin Pathol 2006; 59: 264-268 (Pubitemid 43344887)
37. Horny HP, Sotlar K, Valent P: Mastocytosis: state of the art. Pathobiology 2007; 74: 121- 132 (Pubitemid 46985284)
38. Huang HH, Zhu JY, Han JY, Shen LJ, Xu L, Chen XL, Zheng LY, Chen FY: Co-existent de novo myelodysplastic syndrome and T-cell non-Hodgkin lymphoma: a common origin or not? J Int Med Res 2009; 37: 270-276
39. Ichinohasama R, Miura I, Takahashi N, Sugawara T, Tamate E, Endoh K, Endoh F, Naganuma H, DeCoteau JF, Griffin JD, Kadin ME, Ooya K: Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Phpositive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Leukemia 2000; 14: 169-182 (Pubitemid 30068389)
40. Jacobson J, Barlogie B, Shaughnessy J, Drach J, Tricot G, Fassas A, Zangari M, Giroux D, Crowley J, Hough A, Sawyer J: MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplants. Br J Haematol 2003; 122: 430-440 (Pubitemid 36951627)
41. Jacobsen N, Theilade K, Videbaek A: Two additional cases of coexisting polycythaemia vera and chronic lymphocytic leukaemia. Scand J Haematol 1982; 29: 405-410 (Pubitemid 13253519)
42. James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C, Garçon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144-1148 (Pubitemid 40663494)
43. Januszewicz E, Firkin FC: Dual presentation of polycythaemia vera and lymphatic leukaemia. Aust NZ J Med 1980; 10: 209-211 (Pubitemid 10064658)
44. Kelsey PR, Patel K: Essential thrombocythaemia followed by multiple myeloma in the same patient. Clin Lab Haematol 1995; 17: 349-351 (Pubitemid 26080277)
45. Kim Y, Weiss LM, Chen YY, Pullarkat V: Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma. Leuk Res 2007; 31: 1749-1754 (Pubitemid 350051404)
46. Kobayashi Y, Nakayama M, Uemura N, Takeyama K, Tobinai K, Takenaka T, Choi SH, Satoh H, Mori S, Asano S: Analysis of myelodysplastic syndrome clones arising after multiple myeloma: a case study by correlative interphase cytogenetic analysis. Jpn J Clin Oncol 1999; 29: 374-377
47. Koza I, Babusikova O: Sequential development of chronic lymphocytic leukemia in a patient with polycythemia vera. Neoplasma 1988; 35: 77-80
48. Kuroda J, Matsumoto Y, Tanaka R, Kurita K, Kobayashi T, Shimizu D, Kimura S, Ashihara E, Horiike S, Shimazaki C, Taniwaki M: JAK2V617F-positive essential thrombocythemia and multiple myeloma with IGH/ CCND1 gene translocation coexist, but originate from separate clones. Acta Haematol 2008; 120: 177-181
49. Lai R, Arber DA, Brynes RK, Chan O, Chang KL: Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome. A report of five cases and review of the literature. Am J Clin Pathol 1999; 111: 373-378 (Pubitemid 29102746)
50. Liu ML, Kallakury B, Kessler C, Hartmann DP, Azumi N, Ozdemirli M: Chronic idiopathic myelofibrosis terminating in extramedullary anaplastic plasmacytoma. Leuk Lymphoma 2006; 47: 315-322 (Pubitemid 43084573)
51. Massa FS, Rolón JM, Pavlovsky S: Myelofibrosis with myeloid metaplasia in a patient with relapsed Hodgkin's lymphoma who underwent autologous hematopoietic stem cell transplantation. Hematology 2007; 12: 487- 488 (Pubitemid 350048056)
52. McLaughlin P, Estey E, Glassman A, Romaguera J, Samaniego F, Ayala A, Hayes K, Maddox AM, Preti HA, Hagemeister FB: Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. Blood 2005; 105: 4573-4575 (Pubitemid 40807273)
53. Mitterbauer G, Schwarzmeier J, Mitterbauer M, Jaeger U, Fritsch G, Schwarzinger I: Myelodysplastic syndrome/acute myeloid leukemia supervening previously untreated chronic B-lymphocytic leukemia: demonstration of the concomitant presence of two different malignant clones by immunologic and molecular analysis. Ann Hematol 1997; 74: 193-197 (Pubitemid 27198792)
54. Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Larson RA, Schiffer CA: Therapyrelated myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 2002; 20: 3878-3884
55. Mossafa H, Fourcade C, Pulic M, Jary L, Cheze S, Szpiro-Tapia S, Troussard X: Chronic lymphocytic leukemia associated with myelodysplastic syndrome and/or chronic myeloid leukemia: evidence for independent clonal chromosomal evolution. Leuk Lymphoma 2001; 41: 337-341 (Pubitemid 32499416)
56. Nieto LH, Raya Sánchez JM, Arguelles HA, Brito Barroso ML, González BG: A case of chronic lymphocytic leukemia overwhelmed by rapidly progressive idiopathic myelofibrosis. Haematologica 2000; 85: 973-977
57. Nilsson T, Nilsson L, Lenhoff S, Rylander L, Astrand-Grundström I, Strömbeck B, Höglund M, Turesson I, Westin J, Mitelman F, Jacobsen SE, Johansson B: MDS/AML-Associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q). Genes Chromosomes Cancer 2004; 41: 223-231 (Pubitemid 39299292)
58. Orciuolo E, Fazzi R, Galimberti S, Testi C, Azzara' A, Carulli G, Petrini M: Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy. Leuk Res 2006; 30: 349-353 (Pubitemid 43053233)
59. Pajor L, Kereskai L, Tamaska P, Vass JA, Radvanyi G: Coexistence of chronic myeloid leukemia and hairy cell leukemia of common clonal origin. Cancer Genet Cytogenet 2002; 134: 114-117 (Pubitemid 34553453)
60. Papayannis AG, Nikiforakis E, Aanagnostou- Keramida D: Development of chronic lymphocytic leukaemia in a patient with polycythaemia vera. Scand J Haematol 1982; 29: 65-69 (Pubitemid 12050219)
61. Park TS, Cheong JW, Song J, Choi JR: Therapy- related myelodysplastic syndrome with der(17)t(12; 17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia. Leuk Res 2009; 33: 1001-1004
62. Polkowska-Kulesza E, Matusewicz W, Golebiowska A, Najder M, Urbanska-Rys H, Jodlowska E: The coexistence of chronic lymphocytic leukaemia and polycythaemia vera terminating in acute myeloid leukaemia. Folia Haematol Int Mag Klin Morphol Blutforsch 1988; 115: 647-652
63. Prósper F, Borbolla JR, Rifón J, Cuesta B, Fernández J, Pinacho A, Rocha E: Coexistence of essential thrombocythemia and multiple myeloma. Ann Hematol 1992; 65: 103-105
64. Przepiorka D, Buadi F, McClune B, Franz G, Walsh W, White F: Myelodysplastic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. Bone Marrow Transplant 2007; 40: 759- 764 (Pubitemid 47521535)
65. Pulsoni A, Bianco P, La Verde G, Mecarocci S, Petrucci MT, Torromeo C, Avvisati G: Coexistent multiple myeloma and myelofibrosis. Leuk Lymphoma 1993; 10: 401-403 (Pubitemid 23256621)
66. Robak T, Urbańska-Ryś H, Góra-Tybor J, Wawrzyniak E, Korycka A, Bartkowiak J, Kordek R, Polliack A: Coexistence of chronic lymphocytic leukemia and essential thrombocythemia. Leuk Lymphoma 2003; 44: 1425-1431 (Pubitemid 36764301)
67. Robertson LE, Estey E, Kantarjian H, Koller C, O'Brien S, Brown B, Keating MJ: Therapyrelated leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia. Leukemia 1994; 8: 2047-2051
68. Rizzi R, Liso A, Pannunzio A, Carluccio P, Specchia G, Liso V: Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature. Leuk Lymphoma 2002; 43: 2217-2220 (Pubitemid 35174737)
69. Saba NF, Warth JA, Ross DG: Simultaneous occurrence of polycythemia vera and Waldenstrom macroglobulinemia: a case report and review of the literature. Haematologia (Budap) 2002; 32: 17-23 (Pubitemid 36002083)
70. Saletti P, Ghielmini M, Scali G, Pedrinis E, Guéneau M, Cavalli F: Hodgkin's and Castleman's disease in a patient with systemic mastocytosis. Ann Hematol 1999; 78: 97-100 (Pubitemid 29132444)
71. Schlaifer D, Dastugue N, Brousset P, Delsol G, Muller C, Rigal-Huguet F, Attal M, Laurent G, Pris J: B-cell lymphoma following polycythemia vera: evidence for the involvement of two different clones. Leukemia 1994; 8: 895-896 (Pubitemid 24161101)
72. Schmetzer HM, Mittermüller J, Duell T, Wilmanns W: Development of myeloma and secondary myelodysplastic syndrome from a common clone. Cancer Genet Cytogenet 1998; 100: 31-35 (Pubitemid 128766339)
73. Sever M, Jorgensen JL, Gurevich I, Pinheiro M, Verstovsek S: Primary myelofibrosis with concurrent precursor T-cell lymphoblastic lymphoma of the spleen in a 26-year-old patient. Leuk Res 2009; 33):e186-e188
74. Shibata K, Shimamoto Y, Nakazato S, Matsuzaki M, Tadano J: Refractory anaemia with ringed sideroblasts concurrent with multiple myeloma - a brief review of the recent literature. Haematologia (Budap) 1997; 28: 199-205 (Pubitemid 128536944)
75. Soenen V, Preudhomme C, Roumier C, Laï JL, Lepelley P, Facon T, Pagniez D, Fenaux P: Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells. Leukemia 1998; 12: 238-241 (Pubitemid 28108078)
76. Steinmetz C, Shabaik A, Hasteh F: Systemic mastocytosis associated with small lymphocytic lymphoma: an incidental finding in a patient with invasive gastric adenocarcinoma. Diagn Cytopathol 2007; 35: 728-733 (Pubitemid 350035048)
77. Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, Oizumi K: Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature. Acta Haematol 1998; 99: 221-223 (Pubitemid 28230392)
78. Terpstra WE, Meuwissen OJ, Hagemeijer A, Michiels JJ: Multiple myeloma and acute megakaryoblast leukemia in spent phase polycythemia vera. Am J Clin Pathol 1990; 94: 786-790
79. Tsiara S, Economou G, Panteli A, Isaakidis P, Kapsali E, Bourantas KL: Coexistence of myelodysplastic syndrome and multiple myeloma. J Exp Clin Cancer Res 1999; 18: 565-566 (Pubitemid 30114748)
80. Ueki K, Sato S, Tamura J, Sawamura M, Murakami H, Naruse T, Tsuchiya J: Three cases of multiple myeloma developing into melphalan- related chronic myelomonocytic leukemia. J Med 1991; 22: 157-161
81. Yaǧci M, Sucak GT, Oǧur G, Haznedar R: Therapy-related refractory anemia with ringed sideroblasts in chronic lymphocytic leukemia. Involvement of 3q21 region. Cancer Genet Cytogenet 2001; 129: 43-46 (Pubitemid 32743378)
82. Zámecníková A, Vranovský A, Hlavcák P: Coexistence of Philadelphia-positive chronic granulocytic leukemia and diffuse large Bcell lymphoma at initial diagnosis. Leuk Lymphoma 2002; 43: 429-431 (Pubitemid 34202127)
83. Cehreli C, Undar B, Akkoc N, Onvural B, Altungoz O: Coexistence of chronic neutrophilic leukemia with light chain myeloma. Acta Haematol 1994; 91: 32-34 (Pubitemid 24131999)
84. Dinçol G, Nalçaci M, Doǧan O, Aktan M, Küçükkaya R, Aǧan M, Dinçol K: Coexistence of chronic neutrophilic leukemia with multiple myeloma. Leuk Lymphoma 2002; 43: 649-651 (Pubitemid 34232938)
85. Franchi F, Seminara P, Giunchi G: Chronic neutrophilic leukemia and myeloma. Report on long survival. Tumori 1984; 70: 105-107
86. Ito K, Usuki K, Iki S, Urabe A: Chronic neutrophilic leukemia associated with chronic lymphocytic leukemia. Int J Hematol 1998; 68: 87-94 (Pubitemid 28368174)
87. Lewis MJ, Oelbaum MH, Coleman M, Allen S: An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. Br J Haematol 1986; 63: 173-180 (Pubitemid 16113742)
88. Rovira M, Cervantes F, Nomdedeu B, Rozman C: Chronic neutrophilic leukaemia preceding for seven years the development of multiple myeloma. Acta Haematol 1990; 83: 94-95 (Pubitemid 20043278)
89. Standen GR, Steers FJ, Jones L: Clonality of chronic neutrophilic leukaemia associated with myeloma: analysis using the X-linked probe M27 beta. J Clin Pathol 1993; 46: 297- 298 (Pubitemid 23138739)
90. Standen GR, Jasani B, Wagstaff M, Wardrop CA: Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression. Cancer 1990; 66: 162-166 (Pubitemid 20197102)
91. Zoumbos NC, Chrysanthopoulos C, Starakis J, Kapatais-Zoumbos K: Kappa light chain myeloma developing in a patient with chronic neutrophilic leukaemia. Br J Haematol 1987; 65: 504-505
92. Hussein K, Bock O, Theophile K, von Neuhoff N, Buhr T, Schlué J, Büsche G, Kreipe H: JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis. Exp Hematol 2009; 37: 1186-1193.e7
93. Hussein K, Bock O, Theophile K, Schlue J, Ballmaier M, Kröger N, Göhring G, Büsche G, Kreipe H: Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPLW515L/JAK2V617F mutation. Blood 2009; 113: 1391-1392
94. Ishii T, Bruno E, Hoffman R, Xu M: Involvement of various hematopoietic cell lineages by the JAK2V617F mutation in polycythemia vera. Blood 2006; 108: 3128-3134
95. Takahashi N, Miura I, Saitoh K, Miura AB: Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-Activated cell sorting and fluorescence in situ hybridization. Blood 1998; 92: 4758-4763 (Pubitemid 29005878)
96. Culligan DJ, Cachia P, Whittaker J, Jacobs A, Padua RA: Clonal lymphocytes are detectable in only some cases of MDS. Br J Haematol 1992; 81: 346-352
97. Tefferi A, Lasho TL, Schwager SM, Steensma DP, Mesa RA, Li CY, Wadleigh M, Gary Gilliland D: The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates. Br J Haematol 2005; 131: 320-318
98. Sozer S, Fiel MI, Schiano T, Xu M, Mascarenhas J, Hoffman R: The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome. Blood 2009; 113: 5246-5249
99. Gattenlohner S, Ertl G, Einsele H, Kircher S, Muller-Hermelink HK, Marx A: Cardiac JAK2 mutation V617F in a patient with cardiomyopathy and myeloproliferative disease. Ann Intern Med 2008; 149: 69-71 (Pubitemid 351931150)
100. Levine RL, Loriaux M, Huntly BJ, Loh ML, Beran M, Stoffregen E, Berger R, Clark JJ, Willis SG, Nguyen KT, Flores NJ, Estey E, Gattermann N, Armstrong S, Look AT, Griffin JD, Bernard OA, Heinrich MC, Gilliland DG, Druker B, Deininger MW: The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood 2005; 106: 3377- 3379 (Pubitemid 41609169)
101. Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, Yoo NJ, Lee SH: JAK2 V617F mutation is uncommon in non-Hodgkin lymphomas. Leuk Lymphoma 2006; 47: 313-314 (Pubitemid 43084572)
102. Wang YL, Lee JW, Kui JS, Chadburn A, Cross NC, Knowles DM, Coleman M: Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals. Acta Haematol 2007; 118: 209-214 (Pubitemid 351182632)
103. Najfeld V, Cozza A, Berkofsy-Fessler W, Prchal J, Scalise A: Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V 1 F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms. Exp Hematol 2007; 35: 1668-1676. (Pubitemid 47633779)